Cargando…

Cancer immunotherapy: Re-programming cells of the innate and adaptive immune systems

Cancers utilize multiple mechanisms to overcome immune responses. Emerging evidence suggest that immunotherapy of cancer should focus on inducing and re-programming cells of the innate and adaptive immune systems rather than focusing solely on T cells. Recently, we have shown that such a multifacete...

Descripción completa

Detalles Bibliográficos
Autores principales: Manjili, Masoud H., Payne, Kyle K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377002/
https://www.ncbi.nlm.nih.gov/pubmed/22720242
http://dx.doi.org/10.4161/onci.1.2.18113
_version_ 1782235900285026304
author Manjili, Masoud H.
Payne, Kyle K.
author_facet Manjili, Masoud H.
Payne, Kyle K.
author_sort Manjili, Masoud H.
collection PubMed
description Cancers utilize multiple mechanisms to overcome immune responses. Emerging evidence suggest that immunotherapy of cancer should focus on inducing and re-programming cells of the innate and adaptive immune systems rather than focusing solely on T cells. Recently, we have shown that such a multifaceted approach can improve immunotherapy of breast cancer.
format Online
Article
Text
id pubmed-3377002
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-33770022012-06-20 Cancer immunotherapy: Re-programming cells of the innate and adaptive immune systems Manjili, Masoud H. Payne, Kyle K. Oncoimmunology Review Cancers utilize multiple mechanisms to overcome immune responses. Emerging evidence suggest that immunotherapy of cancer should focus on inducing and re-programming cells of the innate and adaptive immune systems rather than focusing solely on T cells. Recently, we have shown that such a multifaceted approach can improve immunotherapy of breast cancer. Landes Bioscience 2012-03-01 /pmc/articles/PMC3377002/ /pubmed/22720242 http://dx.doi.org/10.4161/onci.1.2.18113 Text en Copyright © 2012 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Review
Manjili, Masoud H.
Payne, Kyle K.
Cancer immunotherapy: Re-programming cells of the innate and adaptive immune systems
title Cancer immunotherapy: Re-programming cells of the innate and adaptive immune systems
title_full Cancer immunotherapy: Re-programming cells of the innate and adaptive immune systems
title_fullStr Cancer immunotherapy: Re-programming cells of the innate and adaptive immune systems
title_full_unstemmed Cancer immunotherapy: Re-programming cells of the innate and adaptive immune systems
title_short Cancer immunotherapy: Re-programming cells of the innate and adaptive immune systems
title_sort cancer immunotherapy: re-programming cells of the innate and adaptive immune systems
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377002/
https://www.ncbi.nlm.nih.gov/pubmed/22720242
http://dx.doi.org/10.4161/onci.1.2.18113
work_keys_str_mv AT manjilimasoudh cancerimmunotherapyreprogrammingcellsoftheinnateandadaptiveimmunesystems
AT paynekylek cancerimmunotherapyreprogrammingcellsoftheinnateandadaptiveimmunesystems